Founded in 2007 and headquartered in the United Kingdom, Phastar stands out in the Biotechnology, Data Analytics, Life Sciences, Medical Devices, and Pharmaceutical sectors with its slogan, "Bringing data to life." It is an award-winning specialist biometrics and data science CRO that is highly trusted by leading pharma, biotech, and medical device companies globally.
What sets Phastar apart is its capacity to transform complex trial data into clear, actionable intelligence, thus expediting the drug development process. Leveraging cutting-edge technology, AI-enhanced analytics, and deep therapeutic expertise, the company accelerates regulatory approvals, ensures compliance with global standards, and reduces risk.
The firm's last investment event, a Growth Equity VC on January 1, 2021, drew interest from Charterhouse Capital Partners. This financial backing underscores investor confidence in its scalable, tailored solutions aimed at bringing life-changing therapies to market faster.